Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs. (2016)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1242/dev.138081
PubMed Identifier: 27899508
Publication URI: http://europepmc.org/abstract/MED/27899508
Type: Journal Article/Review
Volume: 143
Parent Publication: Development (Cambridge, England)
Issue: 23
ISSN: 0950-1991